Trial Profile
b. p. m Study (Beats Per Minute): Heart Rate Development Whilst Treating Patients With Hypertension With Concor or Concor Plus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary) ; Bisoprolol/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 09 Nov 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 09 Nov 2011 Actual initiation date changed from Apr 2009 to Jun 2009 as reported by ClinicalTrials.gov.
- 09 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.